These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 528375

  • 1. Synthesis and antibacterial activity of 1-N-(1,3-dihydroxy-2-propyl)kanamycin B (UK-31,214).
    Richardson K, Brammer KW, Jevons S, Plews RM, Wright JR.
    J Antibiot (Tokyo); 1979 Oct; 32(10):973-7. PubMed ID: 528375
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives.
    Richardson K, Jevons S, Moore JW, Ross BC, Wright JR.
    J Antibiot (Tokyo); 1977 Oct; 30(10):843-6. PubMed ID: 591447
    [Abstract] [Full Text] [Related]

  • 3. [Experimental study of the antibacterial activity and chemotherapeutic effectiveness of amikacin sulfate].
    Lobuseva AN, Kuznetsova SM, Samoĭlova LN.
    Antibiot Med Biotekhnol; 1985 Oct; 30(10):776-80. PubMed ID: 4091515
    [Abstract] [Full Text] [Related]

  • 4. Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
    Kumar V, Remers WA.
    J Med Chem; 1979 Apr; 22(4):432-6. PubMed ID: 107311
    [Abstract] [Full Text] [Related]

  • 5. Aminoglycoside antibiotics. XII. Effect of N-alkylation in kanamycin antibiotics.
    Nakagawa S, Toda S, Abe Y, Yamashita H, Fujisawa KI, Naito T, Kawaguchi H.
    J Antibiot (Tokyo); 1978 Jul; 31(7):675-80. PubMed ID: 690002
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
    Van Schepdael A, Busson R, Vanderhaeghe HJ, Claes PJ, Verbist L, Mingeot-Leclercq MP, Brasseur R, Tulkens PM.
    J Med Chem; 1991 Apr; 34(4):1483-92. PubMed ID: 2016726
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S, Vera D, Ramírez-Ronda CH.
    Am J Med; 1986 Jun 30; 80(6B):65-70. PubMed ID: 3014877
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E, Schoutens E, Vanderlinden MP.
    Chemotherapy; 1975 Jun 30; 21(1):45-51. PubMed ID: 807457
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The antibacterial activity of amikacin in comparison with four other aminoglycoside antibiotics (proceedings)].
    Schassan HH.
    Zentralbl Bakteriol Orig A; 1976 Aug 30; 235(1-3):320-8. PubMed ID: 983520
    [No Abstract] [Full Text] [Related]

  • 19. Aminoglycoside antibiotics. 3. Epimino derivatives of neamine, ribostamycin, and kanamycin B.
    Kumar V, Jones GS, Blacksberg I, Remers WA, Misiek M, Pursiano TA.
    J Med Chem; 1980 Jan 30; 23(1):42-9. PubMed ID: 6244410
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.